ARAY
NASDAQ
$0.25
Accuray Inc (ARAY)
Accuray Incorporated designs, develops and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body in the Americas, Europe, the Middle East, India, Japan, Africa and the rest of the Asia Pacific region. The company is headquartered in Sunnyvale, California.
Sector:
Healthcare
Industry:
Medical Devices
Hold
Target: $0.35 (+39.89%)
Market Cap
$33M
P/B Ratio
0.78
Free Cash Flow Yield
7.02%
Beta (5Y)
1.87
Price Chart
Valuation
Market Cap$33M
Forward P/E94.34
P/S0.07
P/B0.78
Profitability
Total Revenue (TTM)$414M
Gross Profit (TTM)$115M
EBITDA-$24M
Profit Margin-11.3%
Operating Margin-8.7%
EPS-$0.42
Financial Health
Debt-to-Equity348.1%
Free Cash Flow Yield7.02%
Growth & Risk
Revenue 5Y CAGR+1.89%
FCF 5Y CAGR-35.72%
Beta (5Y)1.87
Sharpe Ratio-1.22